In view of the dramatic surge of counterfeit drugs and resulting threats to public health, monitoring the quality of pharmaceuticals is playing an increasingly important role in the protection of consumers, particularly in developing countries.
In some regions of Africa, Latin America and Asia, up to 30% of all drugs sold today are counterfeits, laced or adulterated. This gives rise to a wide range of health risks for patients and consumers.
Given the complicated, expensive methods of testing pharmaceuticals, there are hardly any dependable facilities in developing countries that are able to verify the identity and content of medications on a regular basis.
Global Pharma Health Fund e.V. (GPHF) has therefore developed the concept of a mobile, compact lab for the fast, inexpensive identification of drug counterfeits.
TTM has been cooperating with GPHF for years now – they build the portable mini labs by order of GPHF and send them to public, privately operated and church-run medicine facilities around the world. Over 350 mini labs have already been dispatched to 70 different countries.
Learn more about the GPHF mini lab here.
GPHF News: